ARCHIVES

Ohio State to study center expansion.

This article is from The Cancer Letter archive.

Vol. 29 No. 35 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

“Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes

November 1, 1974